Edgewise Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Edgewise Therapeutics Inc
TickerEWTX
CIK #0001710072
CUSIP28036F105
SectorLife Sciences - Pharmaceutical Preparations
Address3415 Colorado Ave, Boulder, CO 80303
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Edgewise Therapeutics Inc 2020-12-10 95.0 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001710072] 10-K
[0001710072] 10-Q
[0001710072] 3
[0001710072] 4
[0001710072] 8-K
[0001710072] D
[0001710072] SC 13D
[0001710072] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Janus Henderson Group PLC Edgewise Therapeutics Inc [2026-05-15] 0.0
Perceptive Advisors LLC Edgewise Therapeutics Inc [2025-02-21] 0.0
Janus Henderson Group PLC Edgewise Therapeutics Inc [2025-02-14] 0.0
Paradigm Biocapital Advisors LP Edgewise Therapeutics Inc [2025-02-03] 0.0
Baker Bros Advisors LP Edgewise Therapeutics Inc [2024-11-14] 6.2
BlackRock Inc Edgewise Therapeutics Inc [2024-11-08] 6.8
BlackRock Inc Edgewise Therapeutics Inc [2024-10-22] 6.8
BlackRock Inc Edgewise Therapeutics Inc [2024-02-02] 5.2
RA Capital Management LP Edgewise Therapeutics Inc [2024-01-29] 9.6
EcoR1 Capital LLC Edgewise Therapeutics Inc [2022-09-26] 5.5
Deep Track Capital LP Edgewise Therapeutics Inc [2022-09-23] 5.34
RA Capital Management LP Edgewise Therapeutics Inc [2022-02-14] 5.3
FMR LLC Edgewise Therapeutics Inc [2022-02-09] 0.0
Citadel Advisors LLC Edgewise Therapeutics Inc [2022-01-13] 5.0
Citadel Advisors LLC Edgewise Therapeutics Inc [2021-07-12] 4.8
Cormorant Global Healthcare Master Fund LP Edgewise Therapeutics Inc [2021-05-18] 3.37
US Venture Partners Xi LP Edgewise Therapeutics Inc [2021-05-03] 7.1
OrbiMed Advisors LLC Edgewise Therapeutics Inc [2021-04-08] 27.8
Viking Global Investors LP Edgewise Therapeutics Inc [2021-04-05] 7.0
Novo Holdings A/S Edgewise Therapeutics Inc [2021-03-31] 11.4
Flynn James E Edgewise Therapeutics Inc [2021-03-30] 8.27
Form 3/4/5 Filer 2011 - 2026
Edgewise Therapeutics Inc
Russell Alan J
Fox Jonathan C
Brege Laura
Morris Arlene
Thompson Peter A
Edris Badreddin
Martin Christopher Nathan
Donovan Joanne M
Nofi Michael
Blaustein Robert
Moore John R
Koch Kevin
Derakhshan Behrad
Carruthers R Michael
Root Jonathan D
OrbiMed Advisors LLC
OrbiMed Capital GP VI LLC
OrbiMed Genesis GP LLC
Semigran Marc
Novo Holdings A/S
Wellington Biomedical Innovation Master Investors Cayman I
Deerfield Private Design Fund IV LP
Deerfield Management Company LP
Flynn James E
Deerfield Mgmt IV LP
Harrison Kenneth PhD
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Donovan Joanne M
Common Stock
2026-03-31 Sell 21,338 $32.12 685,377
Donovan Joanne M
Stock Option (Right to Buy) · derivative
2026-03-31 Option exercise 21,338 $0.00
Donovan Joanne M
Common Stock
2026-03-31 Option exercise 21,338 $7.08 151,073
Donovan Joanne M
Common Stock
2026-03-27 Sell 9,623 $30.98 298,121
Donovan Joanne M
Common Stock
2026-03-27 Sell 6,735 $30.98 208,650
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 17,236 $0.00
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 7,605 $0.00
Edris Badreddin
Common Stock
2026-01-21 Sell 66,477 $29.44 1,957,083
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 66,477 $0.00
Edris Badreddin
Common Stock
2026-01-21 Option exercise 66,477 $1.93 128,301
Edris Badreddin
Common Stock
2026-01-21 Sell 10,463 $29.44 308,031
Edris Badreddin
Common Stock
2026-01-21 Option exercise 17,236 $0.64 11,031
Edris Badreddin
Common Stock
2026-01-21 Sell 13,690 $29.44 403,034
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 13,690 $0.00
Edris Badreddin
Common Stock
2026-01-21 Sell 7,605 $29.44 223,891
Edris Badreddin
Common Stock
2026-01-21 Option exercise 7,605 $0.71 5,400
Edris Badreddin
Common Stock
2026-01-21 Option exercise 13,690 $0.39 5,339
Edris Badreddin
Common Stock
2026-01-21 Option exercise 10,463 $1.93 20,194
Edris Badreddin
Stock Option (Right to Buy) · derivative
2026-01-21 Option exercise 10,463 $0.00
Edris Badreddin
Common Stock
2026-01-21 Sell 17,236 $29.44 507,428
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 217 119,636,562
2025-12-31 203 122,757,403
2025-09-30 176 112,286,014
2025-06-30 179 118,846,838
2025-03-31 201 109,668,768
2024-12-31 208 99,928,997
2024-09-30 181 104,003,649
2024-06-30 141 101,492,573
2024-03-31 130 92,455,346
2023-12-31 117 79,886,195
2023-09-30 86 68,439,950
2023-06-30 96 69,513,016
Form 13F Holdings
Firm Period DFND Voting Shares
Peregrine Capital Management LLC [2026-06-30] SOLE 73,798 198,570
Moody Aldrich Partners LLC [2026-06-30] SOLE 45,745 104,952
Eleva Capital SAS [2026-06-30] SOLE 0 17,460
Connecticut Capital Management Group LLC [2026-06-30] OTR 0 9,824
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 5,466 5,466
PSP Research LLC [2026-06-30] SOLE 0 5,000
Gamma Investing LLC [2026-06-30] DFND 2,107 2,107
Farther Finance Advisors LLC [2026-06-30] SOLE 0 558
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 294 294
Fortitude Family Office LLC [2026-06-30] SOLE 160 160
Versant Capital Management Inc [2026-06-30] SOLE 120 120
BFSG LLC [2026-06-30] SOLE 0 100
Handelsbanken Fonder AB [2026-06-30] SOLE 0 30
Ares Financial Consulting LLC [2026-06-30] SOLE 23 23
IFP Advisors LLC [2026-06-30] SOLE 4 4
GHP Investment Advisors Inc [2026-06-30] SOLE 3 3
Hughes Financial Services LLC [2026-06-30] SOLE 3 3
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com